ConductScience.org, home

Paper6479679

Antithrombin III, plasminogen and alpha 2 antiplasmin in jaundice. Clinical usefulness and prognostic significance.

Rodzynek JJ and 4 others. Gut, 1984. Cited by 18 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Antithrombin III, plasminogen and alpha 2 antiplasmin in jaundice. Clinical usefulness and prognostic significance. Papers, record 6479679. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6479679

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Antithrombin III, plasminogen and alpha 2 antiplasmin in jaundice. Clinical usefulness and prognostic significance.
PubMed
Journal
Gut
PubMed
Year
1984
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
18
iCite
Relative citation ratio, by iCite
0.91
iCite
Revised in PubMed
2019-05-01
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Rodzynek JJJ J
2Urbain DD
3Leautaud PP
4Wettendorff PP
5Delcourt AA

Source PubMed

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antithrombin IIIMajor topic
JaundiceMajor topic
PlasminogenMajor topic
alpha-2-AntiplasminMajor topic
Adult
Aged
Blood Coagulation Tests
Cholestasis
Female
Fibrinogen
Humans
Liver Neoplasms
Male
Middle Aged
Prognosis
Prospective Studies

Source PubMed

References17

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
17,461,504Antithrombin III versus prothrombin in liver cirrhosis.Haemostasis1981https://conductscience.org/library/papers/7461504PubMed
26,812,211Low antithrombin III in acute hepatic failure at term.Scand J Haematol1982https://conductscience.org/library/papers/6812211PubMed
37,146,823Improvement of some blood coagulation factors in cirrhotic patients treated with low doses of heparin.Scand J Haematol1982https://conductscience.org/library/papers/7146823PubMed
46,186,045Antithrombin III in rat hepatocytes.Thromb Res1982https://conductscience.org/library/papers/6186045PubMed
57,157,228Synthesis of alpha 2-antiplasmin by rat liver cells.Thromb Res1982https://conductscience.org/library/papers/7157228PubMed
64,120,848Fibrinolysis in cholestatic jaundice.Br Med J1973https://conductscience.org/library/papers/4120848PubMed
74,515,631Value of Normotest and antithrombin 3 in the assessment of liver function.Scand J Gastroenterol Suppl1973https://conductscience.org/library/papers/4515631PubMed
84,515,632Behaviour of antithrombin 3 in liver disease.Scand J Gastroenterol Suppl1973https://conductscience.org/library/papers/4515632PubMed
94,123,935Use of Normotest and Thrombotest, coagulation tests in hepatocellular disease.Scand J Gastroenterol Suppl1973https://conductscience.org/library/papers/4123935PubMed
105,163,179Metabolism of fibrinogen in cirrhosis of the liver.J Clin Invest1971https://conductscience.org/library/papers/5163179PubMed
114,596,237Intravascular coagulation in liver disease.Annu Rev Med1974https://conductscience.org/library/papers/4596237PubMed
12131,986Inhibition of plasmin by normal and antiplasmin-depleted human plasma.Thromb Res1976https://conductscience.org/library/papers/131986PubMed
13935,800Observations of increased levels of blood coagulation factors and other plasma proteins in cholestatic liver disease.Scand J Gastroenterol1976https://conductscience.org/library/papers/935800PubMed
1476,519The alpha2-plasmin inhibitor levels in liver diseases.Clin Chim Acta1978https://conductscience.org/library/papers/76519PubMed
15149,046Methods for determination of plasmin, antiplasmin and plasminogen by means of substrate S-2251.Haemostasis1978https://conductscience.org/library/papers/149046PubMed
167,191,149Effect of hepatectomy on the posttraumatic fibrinolysis inhibition and the primary fibrinolysis inhibitor in the rat.Thromb Res1980https://conductscience.org/library/papers/7191149PubMed
1814,429,572Thrombotest. A new method for controlling anticoagulant therapy.Lancet1959https://conductscience.org/library/papers/14429572PubMed

Genes4

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
FGB2,244PubTator's text mininghttps://conductscience.org/library/genes/2244NCBI Gene
PLG5,340PubTator's text mininghttps://conductscience.org/library/genes/5340NCBI Gene
SERPINC1462PubTator's text mininghttps://conductscience.org/library/genes/462NCBI Gene
SERPINF25,345PubTator's text mininghttps://conductscience.org/library/genes/5345NCBI Gene

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/6479679

GET https://conductscience.org/api/papers/v1/6479679/authors